The use of a somatostatin analog in the treatment of refractory hypotension after cardiopulmonary bypass.

[1]  P. Cooper.  Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[2]  R. Bone,et al.  Gram-negative sepsis. Background, clinical features, and intervention. , 1991, Chest.

[3]  S. Westaby,et al.  Treatment of a malignant bronchial carcinoid affecting the mediastinum and left atrium by radical two stage resection with cardiopulmonary bypass and somatostatin infusion. , 1990, British heart journal.

[4]  L. Kvols,et al.  Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. , 1987, Anesthesiology.

[5]  E. Blackstone,et al.  Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. , 1986, The Annals of thoracic surgery.

[6]  T. Jenssen,et al.  Vasoactive intestinal polypeptide and somatostatin in experimental endogenous gram-negative peritonitis. , 1986, Acta chirurgica Scandinavica.

[7]  L. Kvols,et al.  Rapid reversal of carcinoid crisis with a somatostatin analogue. , 1985, The New England journal of medicine.

[8]  R. Jorde,et al.  Changes in plasma levels of gastrointestinal regulatory peptides during hemorrhagic shock in pigs. , 1985, Acta chirurgica Scandinavica.

[9]  R. Jorde,et al.  Release of gastrointestinal peptides during E. coli endotoxinaemia. , 1984, Acta chirurgica Scandinavica.

[10]  B. Farber,et al.  Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen. , 1983, The Journal of thoracic and cardiovascular surgery.

[11]  S. Efendić,et al.  Circulatory effects of somatostatin in anaesthetized dogs. , 1979, Acta chirurgica Scandinavica.